CA
NZ
UK
AU
IND
US
Humana (NYSE:HUM) shares closed sharply higher on October 9 after the company announced improved Centers for Medicare and Medicaid Services Star Ratings for 2027, with 95% of its Medicare Advantage members now enrolled in plans rated 4.0 stars or above, and 42% in plans …
ImmunityBio (NASDAQ:IBRX) shares closed higher, attracting speculative buying ahead of founder Patrick Soon-Shiong's fireside chat at an oncology investor symposium scheduled for October 16. ImmunityBio is a San Diego-based, commercial-stage immunotherapy company that develops next-generation therapies and vaccines to activate the innate and adaptive …
Iovance Biotherapeutics (NASDAQ:IOVA) shares closed sharply higher after the company raised its 2026 revenue guidance to a range of $410 million to $420 million, up from a prior range of $350 million to $370 million. Iovance Biotherapeutics is a commercial-stage biotechnology company that develops …
Kailera Therapeutics (NASDAQ:KLRA) shares rebounded sharply, closing up more than 16% after touching a fresh 52-week low area near $10 earlier this week. Kailera Therapeutics is an advanced clinical-stage biopharmaceutical company developing a diversified pipeline of injectable and oral GLP-1-based therapies for obesity, with …
Mirum Pharmaceuticals (NASDAQ:MIRM) shares closed sharply higher as investors weighed a string of positive catalysts for the rare disease drugmaker. Mirum Pharmaceuticals is a commercial-stage biopharmaceutical company based in Foster City, California, dedicated to developing and delivering therapies for rare liver and rare genetic …
Moderna (NASDAQ:MRNA) shares surged after the company's entry into the Nasdaq-100 index, replacing Warner Bros. Discovery, took effect before today's market open. Moderna is a biotechnology company that pioneers messenger RNA technology to develop vaccines and therapeutics across infectious disease, oncology, rare disease, and …
Novavax (NASDAQ:NVAX) shares surged on unusually heavy tradingVolumeas investors refocused on the company's partnership-driven turnaround story. Novavax is a biotechnology company that discovers, develops, and commercializes vaccines against serious infectious diseases, best known for its protein-based COVID-19Vaccineand its proprietary Matrix-M adjuvant technology platform.
Teladoc Health (NYSE:TDOC) shares closed higher, rising about 4% in a broad healthcare rebound, bouncing from recent weakness as investors weighed the company's newly launched AI tools for its Solo hospital platform. Teladoc Health is a U.S.-based virtual healthcare company that delivers telehealth services …
UnitedHealth Group (NYSE:UNH) shares closed higher and outperformed a broadly firmer healthcare sector as investors positioned ahead of the company's third-quarter earnings report, scheduled for October 13. UnitedHealth Group is the largest U.S. healthcare company by revenue, operating through its UnitedHealthcare insuranceBusinessand its Optum …
Vaxcyte (NASDAQ:PCVX) shares closed sharply higher as investors continued to digest positive Phase 3 OPUS-1 results for the company's 31-valent pneumococcal conjugate vaccine candidate. Vaxcyte is a clinical-stage vaccine innovation company dedicated to engineering high-fidelity, broad-spectrum conjugate and novel protein vaccines to prevent or …
Please wait processing your request...